Financial comparisons Abbisko Cayman Limited

Equities

Delayed Hong Kong S.E. Other stock markets 03:25:52 17/03/2026 GMT			5-day change	1st Jan Change
12.49 ^HKD	+1.38%		-2.57%	-4.00%

03-16	Abbisko Doses First Patient in Liver Cancer Drug Trial	MT
03-11	Abbisko Drug Receives Rare Pediatric Designation in U.S.	MT

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Revenues (Y-1)	Net Margin (Y-1)	EBIT Margin (Y-1)	ROE (Y-1)	ROA (Y-1)	Leverage (Y-1)
ABBISKO CAYMAN LIMITED	69.05M	5.62%	-4.28%	1.44%	1.34%	-978.21x
ARGENX SE	2.22B	36.99%	-0.96%	2.26%	2.02%	818.71x
WUXI APPTEC CO., LTD.	5.38B	24.08%	29.51%	16.78%	12.27%	-0.97x
INSMED INCORPORATED	606M	-210.54%	-205.59%	-249.28%	-	0.72x
BIONTECH SE	3.37B	-39.59%	-48.95%	-4.4%	-5.08%	11x
WUXI BIOLOGICS (CAYMAN) INC.	2.56B	17.97%	25.37%	11.65%	8.43%	-0.66x
GENMAB A/S	3.69B	25.89%	28.63%	20.56%	12.29%	-1.54x
AKESO, INC.	291M	-24.22%	-26.28%	-8.94%	-4.69%	-2.82x
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	265M	-13.8%	-7.18%	-9.46%	-9.11%	18.95x
EXELIXIS, INC.	2.32B	33.73%	37.59%	35.53%	27.02%	-1.18x
MADRIGAL PHARMACEUTICALS, INC.	958M	-30.08%	-31.31%	-42.49%	-	2.15x
IMMUNITYBIO, INC.	113M	-310.18%	-226%	-	-	-
REMEGEN CO., LTD.	235M	-85.53%	-78.53%	-54.06%	-26.62%	-1.54x
ARROWHEAD PHARMACEUTICALS, INC.	829M	-0.2%	11.86%	-0.5%	-	-6.61x
PHARMAESSENTIA CORPORATION	498M	32.27%	31.52%	16.33%	13.74%	-4x
CYTOKINETICS, INCORPORATED	88.04M	-891.6%	-695.44%	-	-54.35%	0.77x
Average	1.47B	-89.32%	-72.5%	-18.9%	-1.89%	-9.68x
Weighted average by Cap.	2.2B	-55.22%	-50.91%	-28.89%	2.12%	140.16x